AM Report: Stocks Surge As Investors Focus On Prospects For COVID-19 Vaccine

By Tom Piotrowski | More Articles by Tom Piotrowski

US sharemarkets soared on Monday. Drugmaker Moderna’s shares rallied by 20% after the company reported “positive” phase one results for a potential COVID-19 vaccine.